| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.44 | 0.03 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.41 | 0.03 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.38 | 0.07 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.37 | 0.05 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.36 | 0.09 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.35 | 0.08 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.34 | 0.005 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.34 | 0.09 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.33 | 0.09 |